Exact Mass: 560.2457

Chloramphenicol palmitate

2-[(Dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl palmitate

C27H42Cl2N2O6 (560.242)

C254 - Anti-Infective Agent > C258 - Antibiotic Same as: D01072

Isomorellic acid

(2Z)-4-[12-hydroxy-8,8,21,21-tetramethyl-5-(3-methylbut-2-en-1-yl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.0^{2,15}.0^{2,19}.0^{4,13}.0^{6,11}]docosa-4,6(11),9,12,15-pentaen-19-yl]-2-methylbut-2-enoic acid

Morellic acid is found in fruits. Morellic acid is from Garcinia morella (batuan Isomorellic acid is a member of pyranoxanthones. Morellic acid is isolated from Garcinia Morella with an antiangiogenic activity[1]. Morellic acid is isolated from Garcinia Morella with an antiangiogenic activity[1].

Chloramphenicol palmitate

2-(2,2-dichloroacetamido)-3-hydroxy-3-(4-nitrophenyl)propyl hexadecanoate

C27H42Cl2N2O6 (560.242)

Sotorasib

6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-[4-methyl-2-(propan-2-yl)pyridin-3-yl]-4-[(2S)-2-methyl-4-(prop-2-enoyl)piperazin-1-yl]-1H,2H-pyrido[2,3-d]pyrimidin-2-one

C30H30F2N6O3 (560.2347)

D000970 - Antineoplastic Agents > D000074322 - Antineoplastic Agents, Immunological > D000082082 - Immune Checkpoint Inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1902 - Ras Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor Sotorasib (AMG-510) is a first-in-class, orally bioavailable, and selective KRAS G12C covalent inhibitor. Sotorasib irreversibly inhibits KRAS G12C by locking it in an inactive GDP-bound state. Sotorasib is the first KRAS G12C inhibitor in clinical development and leads to the regression of KRAS G12C tumors[1][2]. Sotorasib racemate (Compound A) is an orally active racemate of Sotorasib (HY-114277), a covalent inhibitor of KRAS G12C mutant which induces adaptive feedback activation of MAPK pathway. Sotorasib racemate also exerts inhibitor activity against KRAS G12C induced cancer and can be applied to cancer research[1].

1,2-Dehydrotelobine

(+)-1,2-Dehydrotelobine

C35H32N2O5 (560.2311)

Jatamanvaltrate I

Lancifodilactone E

(+)-Lancifodilactone E

Lancifodilactone L

(3R,3aR,5aS,6S,7aR,8S,9S,11S,13aS,14aR)-dodecahydro-3,8,9-trihydroxy-5,5,11-trimethyl-11-[(2S,3Z)-2-methyl-3-(4-methyl-5-oxofuran-2(5H)-ylidene)propanoyl]-2H,5H-6,8:9,13a-diepoxycycloocta[5,6]cyclohepta[1,2-c]furo[3,2-b]furan-2(14H)-one|schicagenin E

(3R,3aR,5aS,6S,7aR,8S,9S,11S,13aS,14aR)-dodecahydro-3,8,9-trihydroxy-5,5,11-trimethyl-11-[(2S,3Z)-2-methyl-3-(4-methyl-5-oxofuran-2(5H)-ylidene)propanoyl]-2H,5H-6,8:9,13a-diepoxycycloocta[5,6]cyclohepta[1,2-c]furo[3,2-b]furan-2(14H)-one|schicagenin E

dennisic acid B

Scilliglaucoside

tasumatrol H

12-oxo-hellebrigenin-3-O-4,6-dideoxy-alpha-L-ribohexopyranoside|kalanchoside C

Anodendroside G

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]pentanedioic acid

C26H36N6O8 (560.2594)

Gln Asp Gly Asp Leu

C22H36N6O11 (560.2442)

BCP29273

C29H36O11_7,11-Methano-2H,4H-oxireno[1,8]cycloocta[1,2-f][2]benzopyran-8-acetic acid, 10-(acetyloxy)-4-(3-furanyl)dodecahydro-alpha,11-dihydroxy-4a,7,9,9-tetramethyl-2,13-dioxo-, methyl ester, (alphaR,4R,4aR,7S,8S,10S,11S,11aR,12aS)

NCGC00347396-02_C29H36O11_7,11-Methano-2H,4H-oxireno[1,8]cycloocta[1,2-f][2]benzopyran-8-acetic acid, 10-(acetyloxy)-4-(3-furanyl)dodecahydro-alpha,11-dihydroxy-4a,7,9,9-tetramethyl-2,13-dioxo-, methyl ester, (alphaR,4R,4aR,7S,8S,10S,11S,11aR,12aS)-

methyl (2R)-2-[(1S,2R,4S,9R,10R,14S,15S,17S)-17-(acetyloxy)-9-(furan-3-yl)-1-hydroxy-10,14,16,16-tetramethyl-7,18-dioxo-3,8-dioxapentacyclo[12.3.1.0²,⁴.0⁴,¹³.0⁵,¹⁰]octadecan-15-yl]-2-hydroxyacetate

methyl (2R)-2-[(1S,2R,4S,9R,10R,14S,15S,17S)-17-(acetyloxy)-9-(furan-3-yl)-1-hydroxy-10,14,16,16-tetramethyl-7,18-dioxo-3,8-dioxapentacyclo[12.3.1.0²,⁴.0⁴,¹³.0⁵,¹⁰]octadecan-15-yl]-2-hydroxyacetate

O-trimethoxy-3,4,5-benzoyl-vincamajine

3-O-beta-D-glucopyranosyl-3beta,14beta-dihydroxy-11-oxobufa-4,20,22-trienolide

phenylmercuric oleate

C24H38HgO2 (560.2578)

3,3-(3,7,12,17-Tetramethyl-8,13-divinyl-2,18-porphyrindiyl)dipro panoate

C34H32N4O4 (560.2423)

N-s-butyl-N-[(2R,3S)-3-({[(3aS,5R,6aR)-hexahydro-2H-cyclopenta[b]furan-5-yloxy]carbonyl}amino)-2-hydroxy-4-phenylbutyl]-4-(hydroxymethyl)benzenesulfonamide

C29H40N2O7S (560.2556)

3-[(3-Sec-butyl-4-hydroxybenzoyl)amino]azepan-4-YL 4-(2-hydroxy-5-methoxybenzoyl)benzoate

n-1,2,3,4-Tetrahydronaphth-1-yl-2-[3,5-dimethoxybenzamido]-2-deoxy-adenosine

C29H32N6O6 (560.2383)

Protoporphyrin(2-)

C34H32N4O4-2 (560.2423)

Protoporphyrinate

C34H32N4O4-2 (560.2423)

D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents COVID info from COVID-19 Disease Map D003879 - Dermatologic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Gumoside B

A pyridopyrimidine that is pyrido[2,3-d]pyrimidin-2(1H)-one substituted by 4-methyl-2-(propan-2-yl)pyridin-3-yl, (2S)-2-methyl-4-(prop-2-enoyl)piperazin-1-yl, fluoro and 2-fluoro-6-hydroxyphenyl groups at positions 1, 4, 6 and 7, respectively. It is approved for the treatment of patients with non-small cell lung cancer having KRAS(G12C) mutations. D000970 - Antineoplastic Agents > D000074322 - Antineoplastic Agents, Immunological > D000082082 - Immune Checkpoint Inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1902 - Ras Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor Sotorasib (AMG-510) is a first-in-class, orally bioavailable, and selective KRAS G12C covalent inhibitor. Sotorasib irreversibly inhibits KRAS G12C by locking it in an inactive GDP-bound state. Sotorasib is the first KRAS G12C inhibitor in clinical development and leads to the regression of KRAS G12C tumors[1][2]. Sotorasib racemate (Compound A) is an orally active racemate of Sotorasib (HY-114277), a covalent inhibitor of KRAS G12C mutant which induces adaptive feedback activation of MAPK pathway. Sotorasib racemate also exerts inhibitor activity against KRAS G12C induced cancer and can be applied to cancer research[1].

Protoporphyrin(2-)

(1r,2r,4s,6s,7r,8s,9r,10s,11r,13s,15s,16r,17r)-6,7,8,9-tetrahydroxy-8-(hydroxymethyl)-4,17-dimethyl-5-oxo-13-phenyl-15-(prop-1-en-2-yl)-12,14,18-trioxapentacyclo[11.4.1.0¹,¹⁰.0²,⁶.0¹¹,¹⁵]octadecan-16-yl acetate

(1r,2r,4s,6s,7r,8s,9r,10s,11r,13s,15s,16r,17r)-6,7,8,9-tetrahydroxy-8-(hydroxymethyl)-4,17-dimethyl-5-oxo-13-phenyl-15-(prop-1-en-2-yl)-12,14,18-trioxapentacyclo[11.4.1.0¹,¹⁰.0²,⁶.0¹¹,¹⁵]octadecan-16-yl acetate

10,15,27-trihydroxy-9,15-dimethyl-7,12,20,25,28-pentaoxaheptacyclo[21.4.3.1⁸,¹¹.1¹⁰,¹⁴.0¹,²⁴.0⁹,¹⁸.0¹³,¹⁸]dotriaconta-4,22-diene-6,21,26-trione

(1s,3r,7r,10s,12r,13r,15s,16s,17s,18s,21r,22s,24r,26s)-12,15-dihydroxy-9,9,21,24,26-pentamethyl-4,8,19,23,29-pentaoxaoctacyclo[13.13.1.0¹,¹³.0³,⁷.0³,¹⁰.0¹⁶,²⁶.0¹⁷,²⁴.0¹⁸,²²]nonacosane-5,14,20,25-tetrone

(1s,3r,7r,10s,12r,13r,15s,16s,17s,18s,21r,22s,24r,26s)-12,15-dihydroxy-9,9,21,24,26-pentamethyl-4,8,19,23,29-pentaoxaoctacyclo[13.13.1.0¹,¹³.0³,⁷.0³,¹⁰.0¹⁶,²⁶.0¹⁷,²⁴.0¹⁸,²²]nonacosane-5,14,20,25-tetrone

methyl 2-[(1s,3s,5r,7s,8r,10s,12s,13r)-5-(acetyloxy)-13-[(5s)-5-hydroxy-2-oxo-5h-furan-3-yl]-6,6,8,12-tetramethyl-17-methylidene-9,15-dioxo-2,14-dioxatetracyclo[8.6.1.0¹,¹².0³,⁸]heptadecan-7-yl]acetate

methyl 2-[(1s,3s,5r,7s,8r,10s,12s,13r)-5-(acetyloxy)-13-[(5s)-5-hydroxy-2-oxo-5h-furan-3-yl]-6,6,8,12-tetramethyl-17-methylidene-9,15-dioxo-2,14-dioxatetracyclo[8.6.1.0¹,¹².0³,⁸]heptadecan-7-yl]acetate

(1s,3r,7r,10s,12s,13r,15r,17s,18r,21r,22s,23s,25s,29s)-12,18-dihydroxy-9,9,18,23,25-pentamethyl-4,8,16,20,28-pentaoxaoctacyclo[13.12.1.1¹⁵,²².0¹,¹³.0³,⁷.0³,¹⁰.0¹⁷,²¹.0²⁵,²⁹]nonacosane-5,14,19,24-tetrone

(1s,3r,7r,10s,12s,13r,15r,17s,18r,21r,22s,23s,25s,29s)-12,18-dihydroxy-9,9,18,23,25-pentamethyl-4,8,16,20,28-pentaoxaoctacyclo[13.12.1.1¹⁵,²².0¹,¹³.0³,⁷.0³,¹⁰.0¹⁷,²¹.0²⁵,²⁹]nonacosane-5,14,19,24-tetrone

C27H44O10S (560.2655)

{"Ingredient_id": "HBIN017151","Ingredient_name": "aspidistrogenin a","Alias": "NA","Ingredient_formula": "C27H44O10S","Ingredient_Smile": "CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6(C5(C(C(C(C6O)O)OS(=O)(=O)O)O)C)O)C)C)OC1","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1899","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

13,27-dimethoxy-22-methyl-15,29,31-trioxa-7,22-diazaoctacyclo[19.9.3.2¹⁶,¹⁹.1⁴,³⁰.1¹⁰,¹⁴.0³,⁸.0²⁵,³³.0²⁸,³²]heptatriaconta-1,3,7,10,12,14(37),16,18,25(33),26,28(32),30(34),35-tridecaene

13,27-dimethoxy-22-methyl-15,29,31-trioxa-7,22-diazaoctacyclo[19.9.3.2¹⁶,¹⁹.1⁴,³⁰.1¹⁰,¹⁴.0³,⁸.0²⁵,³³.0²⁸,³²]heptatriaconta-1,3,7,10,12,14(37),16,18,25(33),26,28(32),30(34),35-tridecaene

C35H32N2O5 (560.2311)

(3r,5s,7r,9r,10s,12r,14r,15r,17s,18s,19r,22s,23s)-10,17,22-trihydroxy-9-methoxy-7,14,18-trimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacos-1-en-16-one

(3r,5s,7r,9r,10s,12r,14r,15r,17s,18s,19r,22s,23s)-10,17,22-trihydroxy-9-methoxy-7,14,18-trimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacos-1-en-16-one

3-hydroxy-2-[(1-hydroxy-2,14-dimethyl-15-{5-methyl-2-[2-(1h-pyrrol-2-yl)ethenyl]-4,5-dihydro-1,3-oxazol-4-yl}pentadeca-2,4,6,8,10,12,14-heptaen-1-ylidene)amino]-3-(c-hydroxycarbonimidoyl)propanoic acid

3-hydroxy-2-[(1-hydroxy-2,14-dimethyl-15-{5-methyl-2-[2-(1h-pyrrol-2-yl)ethenyl]-4,5-dihydro-1,3-oxazol-4-yl}pentadeca-2,4,6,8,10,12,14-heptaen-1-ylidene)amino]-3-(c-hydroxycarbonimidoyl)propanoic acid

C31H36N4O6 (560.2635)

(2e)-4-[(1r,2s,17s)-12-hydroxy-8,8,21,21-tetramethyl-5-(3-methylbut-2-en-1-yl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.0²,¹⁵.0²,¹⁹.0⁴,¹³.0⁶,¹¹]docosa-4(13),5,9,11,15-pentaen-19-yl]-2-methylbut-2-enoic acid

methyl 13-ethylidene-8-methyl-18-(3,4,5-trimethoxybenzoyloxy)-8,15-diazahexacyclo[14.2.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵.0¹²,¹⁷]nonadeca-2,4,6-triene-17-carboxylate

(3s,3ar,4s,9s,11as)-4-{[(2r,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-9-hydroxy-3,6,10-trimethyl-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-2-one

(3s,3ar,4s,9s,11as)-4-{[(2r,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-9-hydroxy-3,6,10-trimethyl-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-2-one

C26H40O13 (560.2469)

4-({4-hydroxy-2-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-methoxyphenyl}methyl)-3-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-5-methoxyphenol

10,16,22-trihydroxy-9-methoxy-7,14,18-trimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacos-1-en-17-one

(3e,5s)-3-[(2e,4e,6e)-1-hydroxy-7-[(1s,6s)-6-[(1e,3e,5e)-7-hydroxy-7-[(3z,5s)-5-(hydroxymethyl)-2-methylidene-4-oxopyrrolidin-3-ylidene]hepta-1,3,5-trien-1-yl]cyclohex-2-en-1-yl]hepta-2,4,6-trien-1-ylidene]-5-(hydroxymethyl)-1-methylpyrrolidine-2,4-dione

(3e,5s)-3-[(2e,4e,6e)-1-hydroxy-7-[(1s,6s)-6-[(1e,3e,5e)-7-hydroxy-7-[(3z,5s)-5-(hydroxymethyl)-2-methylidene-4-oxopyrrolidin-3-ylidene]hepta-1,3,5-trien-1-yl]cyclohex-2-en-1-yl]hepta-2,4,6-trien-1-ylidene]-5-(hydroxymethyl)-1-methylpyrrolidine-2,4-dione

(2s,6r)-2-{[(1r,3as,3br,5ar,7r,8r,9as,9bs,11s,11as)-3a,8,11-trihydroxy-9a,11a-dimethyl-10-oxo-1-(5-oxo-2h-furan-3-yl)-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-4-methoxy-6-methyl-2,6-dihydropyran-3-one

(2s,6r)-2-{[(1r,3as,3br,5ar,7r,8r,9as,9bs,11s,11as)-3a,8,11-trihydroxy-9a,11a-dimethyl-10-oxo-1-(5-oxo-2h-furan-3-yl)-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-4-methoxy-6-methyl-2,6-dihydropyran-3-one

(3s,3ar,4s,9r,11ar)-4-{[(2r,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-9-hydroxy-3,6,10-trimethyl-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-2-one

(3s,3ar,4s,9r,11ar)-4-{[(2r,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-9-hydroxy-3,6,10-trimethyl-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-2-one

C26H40O13 (560.2469)

3-hydroxy-2-{[(2e,4e,6e,8e,10e,12e,14e)-1-hydroxy-2,14-dimethyl-15-[(4r,5r)-5-methyl-2-[(1e)-2-(1h-pyrrol-2-yl)ethenyl]-4,5-dihydro-1,3-oxazol-4-yl]pentadeca-2,4,6,8,10,12,14-heptaen-1-ylidene]amino}-3-(c-hydroxycarbonimidoyl)propanoic acid

3-hydroxy-2-{[(2e,4e,6e,8e,10e,12e,14e)-1-hydroxy-2,14-dimethyl-15-[(4r,5r)-5-methyl-2-[(1e)-2-(1h-pyrrol-2-yl)ethenyl]-4,5-dihydro-1,3-oxazol-4-yl]pentadeca-2,4,6,8,10,12,14-heptaen-1-ylidene]amino}-3-(c-hydroxycarbonimidoyl)propanoic acid

7-[(3,4-dihydroxy-6-methyloxan-2-yl)oxy]-3a,5a-dihydroxy-11a-methyl-11-oxo-1-(6-oxopyran-3-yl)-dodecahydrocyclopenta[a]phenanthrene-9a-carbaldehyde

(5as,6r,9s,9as)-9-hydroxy-9-({[2-(hydroxymethyl)-3-[(4s,5r)-5-isopropyl-3-oxo-4,5,6,7-tetrahydro-1h-2-benzofuran-4-yl]prop-2-enoyl]oxy}methyl)-6-isopropyl-1-oxo-3,5a,6,7,8,9a-hexahydro-2-benzoxepine-4-carboxylic acid

(5as,6r,9s,9as)-9-hydroxy-9-({[2-(hydroxymethyl)-3-[(4s,5r)-5-isopropyl-3-oxo-4,5,6,7-tetrahydro-1h-2-benzofuran-4-yl]prop-2-enoyl]oxy}methyl)-6-isopropyl-1-oxo-3,5a,6,7,8,9a-hexahydro-2-benzoxepine-4-carboxylic acid

4-[12-hydroxy-8,8,21,21-tetramethyl-5-(3-methylbut-2-en-1-yl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.0²,¹⁵.0²,¹⁹.0⁴,¹³.0⁶,¹¹]docosa-4(13),5,9,11,15-pentaen-19-yl]-2-methylbut-2-enoic acid

4-[12-hydroxy-8,8,21,21-tetramethyl-5-(3-methylbut-2-en-1-yl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.0²,¹⁵.0²,¹⁹.0⁴,¹³.0⁶,¹¹]docosa-4(13),5,9,11,15-pentaen-19-yl]-2-methylbut-2-enoic acid

(3r,5s,7r,9r,10s,12r,14r,15s,16s,18r,19r,22s,23r)-10,16,22-trihydroxy-9-methoxy-7,14,18-trimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacos-1-en-17-one

(3r,5s,7r,9r,10s,12r,14r,15s,16s,18r,19r,22s,23r)-10,16,22-trihydroxy-9-methoxy-7,14,18-trimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacos-1-en-17-one

(1r,3as,3br,7s,9as,9bs,10r,11ar)-3a,10-dihydroxy-11a-methyl-1-(6-oxopyran-3-yl)-7-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-1h,2h,3h,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-9a-carbaldehyde

(1r,3as,3br,7s,9as,9bs,10r,11ar)-3a,10-dihydroxy-11a-methyl-1-(6-oxopyran-3-yl)-7-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-1h,2h,3h,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-9a-carbaldehyde

(1ar,3r,3ar,4r,5r,6r,7as)-5-(acetyloxy)-6-[(1s,6r)-6-(2-methoxy-2-oxoethyl)-1,5,5-trimethyl-4-oxocyclohex-2-en-1-yl]-3a-methyl-7-methylidene-4-[(2-methylpropanoyl)oxy]-hexahydroindeno[1,7a-b]oxirene-3-carboxylic acid

(1ar,3r,3ar,4r,5r,6r,7as)-5-(acetyloxy)-6-[(1s,6r)-6-(2-methoxy-2-oxoethyl)-1,5,5-trimethyl-4-oxocyclohex-2-en-1-yl]-3a-methyl-7-methylidene-4-[(2-methylpropanoyl)oxy]-hexahydroindeno[1,7a-b]oxirene-3-carboxylic acid

2-({4-hydroxy-2-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-methoxyphenyl}methyl)-5-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-3-methoxyphenol

(1s,3ar,3br,5as,7s,9ar,9bs,11ar)-3a-hydroxy-11a-methyl-1-(6-oxopyran-3-yl)-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-9a-carbaldehyde

(1s,3ar,3br,5as,7s,9ar,9bs,11ar)-3a-hydroxy-11a-methyl-1-(6-oxopyran-3-yl)-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-9a-carbaldehyde

methyl (1r,9s,10s,12s,13z,16s,17s)-13-ethylidene-8-methyl-18-(3,4,5-trimethoxybenzoyloxy)-8,15-diazahexacyclo[14.2.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵.0¹²,¹⁷]nonadeca-2,4,6-triene-17-carboxylate

3a-hydroxy-11a-methyl-1-(6-oxopyran-3-yl)-5a-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-9a-carbaldehyde

3a-hydroxy-11a-methyl-1-(6-oxopyran-3-yl)-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-9a-carbaldehyde

(1s,2r,4ar,5r,8r,8ar)-2-(acetyloxy)-8a-hydroxy-3,8-dimethyl-5-(prop-1-en-2-yl)-2,4a,5,6,7,8-hexahydro-1h-naphthalen-1-yl (2r,4s,6r)-10-chloro-2-hydroxy-8-methyl-7-oxa-5,8-diazatricyclo[7.4.0.0²,⁶]trideca-1(13),9,11-triene-4-carboxylate

(1s,2r,4ar,5r,8r,8ar)-2-(acetyloxy)-8a-hydroxy-3,8-dimethyl-5-(prop-1-en-2-yl)-2,4a,5,6,7,8-hexahydro-1h-naphthalen-1-yl (2r,4s,6r)-10-chloro-2-hydroxy-8-methyl-7-oxa-5,8-diazatricyclo[7.4.0.0²,⁶]trideca-1(13),9,11-triene-4-carboxylate

C29H37ClN2O7 (560.2289)

(2s,4as,4br,5r,6r,6ar,10ar,10br,12ar)-5-(acetyloxy)-2,4b,7,7,10a,12a-hexamethyl-1,4,8,12-tetraoxo-2-propanoyl-octahydrophenanthro[1,2-c]pyran-6-yl acetate

(2z)-4-[(1s,2s,17s,19r)-12-hydroxy-8,8,21,21-tetramethyl-5-(3-methylbut-2-en-1-yl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.0²,¹⁵.0²,¹⁹.0⁴,¹³.0⁶,¹¹]docosa-4(13),5,9,11,15-pentaen-19-yl]-2-methylbut-2-enoic acid

(2z)-4-[(1s,2s,17s,19r)-12-hydroxy-8,8,21,21-tetramethyl-5-(3-methylbut-2-en-1-yl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.0²,¹⁵.0²,¹⁹.0⁴,¹³.0⁶,¹¹]docosa-4(13),5,9,11,15-pentaen-19-yl]-2-methylbut-2-enoic acid

(5as,6r,9s,9as)-9-hydroxy-9-({[(2e)-2-(hydroxymethyl)-3-[(4s,5r)-5-isopropyl-3-oxo-4,5,6,7-tetrahydro-1h-2-benzofuran-4-yl]prop-2-enoyl]oxy}methyl)-6-isopropyl-1-oxo-3,5a,6,7,8,9a-hexahydro-2-benzoxepine-4-carboxylic acid

(5as,6r,9s,9as)-9-hydroxy-9-({[(2e)-2-(hydroxymethyl)-3-[(4s,5r)-5-isopropyl-3-oxo-4,5,6,7-tetrahydro-1h-2-benzofuran-4-yl]prop-2-enoyl]oxy}methyl)-6-isopropyl-1-oxo-3,5a,6,7,8,9a-hexahydro-2-benzoxepine-4-carboxylic acid

(3r,5s,7r,9s,10s,12r,14r,15s,17s,18s,19r,22s,23r)-10,17,22-trihydroxy-9-methoxy-7,14,18-trimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacos-1-en-16-one

2-{[3a,8,11-trihydroxy-9a,11a-dimethyl-10-oxo-1-(5-oxo-2h-furan-3-yl)-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-4-methoxy-6-methyl-2,6-dihydropyran-3-one